Skip to main content

Drug Safety

lupus SLE
Inhibition of B-cell Activating Factor (BAFF) has revolutionised the treatment of patients with systemic lupus erythematosus (SLE). However, outcomes of therapies within the same class (i.e. BAFF-…
Best of
The last day was jammed with important reports and research including the late breaking abstracts.    What imaging modality is best in GCA? Dutch study: n=42 ?GCA got all three of USS, PET/CT, MRI…
pills-384846_640%20%281%29.jpg
A few things we know about opioids: use is common; it’s not efficacious in the treatment of spondyloarthritis; and, there is an opioid epidemic and its users are stigmatized.  Opioid use can weigh…
PMR spotlight
One of the enduring legacies of ACR 2022 for me will be the emphasis on polymyalgia rheumatica (PMR). Despite being highly inflammatory and relatively common, a remarkable paucity of trials have been…
RT @AkhilSoodMD: Abstr #2192 risk of serious infxn in newborns of mothers on TNFi by placental transfer
- % serious infe

Akhil Sood MD AkhilSoodMD

3 weeks 1 day ago
Abstr #2192 risk of serious infxn in newborns of mothers on TNFi by placental transfer - % serious infection in TNFi in high vs low placental transfer (2.1% vs 1.6%) - HR (high vs low) 0.98 (95% CI 0.36-2.61) - No significant difference in risk of serious infxn @RheumNow #ACR22 https://t.co/7Lfpf7PERu
RT @RichardPAConway: Flatman et al. Risk of infections in children with third trimester TNFi use, high vs low (CTZ, ETN)

Richard Conway RichardPAConway

3 weeks 1 day ago
Flatman et al. Risk of infections in children with third trimester TNFi use, high vs low (CTZ, ETN) placental transfer. No difference but wide CIs, aHR 0.98 (0.36, 2.61) @RheumNow #ACR22 Abstr#2192 https://t.co/350UxX9bkL https://t.co/29uOtek8w7
×